| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.15B | +10.9% |
| Cost of Revenue | $4.01B | +10.2% |
| R&D Expense | $198.8M | +2.4% |
| SG&A Expense | $644.6M | +6.7% |
| Operating Income | $1.50B | +14.7% |
| Interest Expense | $83.2M | +3.5% |
| Pre-tax Income | $1.43B | +16.8% |
| Income Tax | $269.1M | +15.5% |
| Net Income | $1.16B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $345.4M | -0.4% |
| Accounts Receivable | $919.3M | +10.9% |
| Inventory | $1.04B | +35.8% |
| Current Assets | $2.53B | +18.8% |
| Total Assets | $12.43B | +4.5% |
| Current Liabilities | $1.56B | +0.1% |
| Long-term Debt | $2.39B | -6.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.15B | -1.0% |
| Capital Expenditures | $139.0M | +25.6% |
| Investing Cash Flow | -$552.8M | +73.1% |
| Financing Cash Flow | -$575.7M | -1563.5% |
| Free Cash Flow | $1.01B | -3.8% |
| +17.1% |
| EPS (Basic) | $5.04 | +17.5% |
| EPS (Diluted) | $5.01 | +17.9% |
| Total Liabilities |
| $4.95B |
| -1.4% |
| Stockholders' Equity | $7.48B | +8.8% |